https://www.selleckchem.com/pr....oducts/s-glutamic-ac
is is the first multidisciplinary collaborative effort to provide individualized patient recommendations for evaluation and treatment of patients with COVID-19 who may have CSS. This working model helped to devise an approach that may have identified patients who were most likely to benefit from biologic therapy in the absence of evidence-based guidelines. The population of adult residential care homes has been shown to have high morbidity and mortality in relation to COVID-19. We examined 3115 hospital discharges to a national
Like
Comment
Share
